SCHEMBL30405474

SCHEMBL30405474

O=[N+]([O-])c1ccccc1OC(O)=S

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.58
TDP1 Q9NUW8 3/20 0.58
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
RECQL P46063 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
KMT2A Q03164 4/20 0.53
MEN1 O00255 2/20 0.53
HPGD P15428 1/20 0.51
CYP1A2 P05177 1/20 0.51
MAPT P10636 1/20 0.51
CYP2C9 P11712 1/20 0.51
ESR2 Q92731 1/20 0.49
HTT P42858 1/20 0.49
KDM4E B2RXH2 2/20 0.47
POLB P06746 2/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
GPR35 Q9HC97 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3406239 0.87 ALDH1A1 (0.56) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL9615027 0.85 ALDH1A1 (0.55) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL57738 0.85 ALDH1A1 (0.58) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL57737 0.85 ALDH1A1 (0.58) ALDH1A1TDP1NPC1RAB9ARECQL
Bicarbonate SCHEMBL18955378 0.83 ALDH1A1 (0.56) ALDH1A1TDP1NPC1RAB9ARECQL
Bicarbonate SCHEMBL18955379 0.83 ALDH1A1 (0.56) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL57736 0.82 ALDH1A1 (0.60) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL29911025 0.82 ALDH1A1 (0.60) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL28793663 0.82 ALDH1A1 (0.60) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL31572517 0.82 ALDH1A1 (0.60) ALDH1A1TDP1NPC1RAB9ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4168002-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS Revolution Medicines, Inc. (US) 2023-04-26 EP disclosed